4-phenylbutyl formate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-phenylbutyl formate
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: SRFSGRNNUZFSIQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  溴甲苯 在 sodium benzoate 、 cerium(III) chloride 、 9,10-二联苯蒽 、 bis(2,4,6-triisopropylphenyl)disulfide 、 四丁基氯化铵 、 二异丁基氢化铝 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 乙腈 为溶剂， 反应 24.42h， 生成 4-phenylbutyl formate
  参考文献：
  名称：

  O−H 轴承基底的氧化还原中性多催化铈光氧化还原裂解

  摘要：

  提出了一种羧酸和半缩醛的一般 β C−C 键断裂反应的方法。目前的工作证明了基于铈的多催化光氧化还原平台能够实现羧酸的直接加氢脱羧以及乳醇衍生物的氧化还原中性环裂解的能力。

  DOI：

  10.1002/chem.202400642

文献信息

• alpha-SUBSTITUTED GLYCINAMIDE DERIVATIVE
  申请人：KISSEI PHARMACEUTICAL CO., LTD.

  公开号：US20160115119A1

  公开（公告）日：2016-04-28

  The present invention is to provide a novel α-substituted glycinamide derivative, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and a pharmaceutical use thereof. The present invention provides a compound represented by the general formula (I), which has TRPM8 inhibitory effects: [wherein A 1 represents a C 6-10 aryl and the like, A 2 represents a C 6-10 aryl and the like, X represents CH and the like, Y represents —CR 1 R 2 — and the like, R 1 and R 2 independently represent a hydrogen atom and the like, R 3 and R 4 independently represent a halogen atom and the like, n is 1 or 2], or a pharmaceutically acceptable salt thereof. Furthermore, the compound (I) of the present invention can be used as an agent for treating or preventing diseases or symptoms caused by hyperexcitability or disorder of afferent neurons.

  本发明旨在提供一种新型的α-取代甘氨酰胺衍生物，或其药用可接受的盐，包含该衍生物的药物组合物，以及该衍生物的医药用途。 本发明提供了一种由通用公式（I）表示的化合物，该化合物具有TRPM8抑制效果： [其中A1代表C6-10芳基等，A2代表C6-10芳基等，X代表CH等，Y代表—CR1R2—等，R1和R2独立代表氢原子等，R3和R4独立代表卤素原子等，n为1或2]，或其药用可接受的盐。此外，本发明的化合物（I）可作为治疗或预防由于传入神经元的过度兴奋或障碍引起的疾病或症状的药物。
• Fluorosulfonic acid compound, process for producing the same, and use thereof
  申请人：Adachi Kenji

  公开号：US20060252961A1

  公开（公告）日：2006-11-09

  The present invention provides novel fluorosulfonic acids and salts thereof having greater stability and higher acidity than conventional fluorosulfonic acids; and synthetic intermediates thereof. The invention also provides processes for producing novel fluorosulfonic acids from which various derivatives can be easily synthesized; and uses of these fluorosulfonic acids. Specifically, the invention provides a compound represented by formula (1): R—S(═O) n —CF 2 —SO 3 H  (1) wherein R is a group bound to an adjacent sulfur atom through a carbon atom, examples of R being an optionally substituted alkyl group, an optionally substituted haloalkyl group, an optionally substituted alkenyl group, an optionally substituted haloalkenyl group, an optionally substituted alkynyl group, an optionally substituted haloalkynyl group, an optionally substituted cycloalkyl group, etc.; and n is 1 or 2. The invention also provides salts of such a compound, etc.

  本发明提供了新型氟磺酸及其盐，其比传统氟磺酸具有更高的稳定性和酸度；以及其合成中间体。该发明还提供了从中可以轻松合成各种衍生物的新型氟磺酸的生产方法；以及这些氟磺酸的用途。具体而言，该发明提供了由下式表示的化合物： R—S(═O) n —CF 2 —SO 3 H  (1) 其中R是通过碳原子与相邻硫原子结合的基团，R的示例包括可选择取代的烷基基团、可选择取代的卤代烷基基团、可选择取代的烯基基团、可选择取代的卤代烯基基团、可选择取代的炔基基团、可选择取代的卤代炔基基团、可选择取代的环烷基基团等；n为1或2。该发明还提供了该化合物的盐等。
• Making Carbonyls of Amides Nucleophilic and Hydroxyls of Alcohols Electrophilic Mediated by SO₂F₂ for Synthesis of Esters from Amides
  作者：Wan-Yin Fang、Gao-Feng Zha、Hua-Li Qin

  DOI：10.1021/acs.orglett.9b03274

  日期：2019.11.1

  promotion of sulfuryl fluoride, the carbonyl groups of amides performed as nucleophiles while the hydroxyl groups of alcohols were activated to functionalize as electrophiles. This study displayed that the amide C-N bonds could be easily cleaved with delicate nucleophiles to form the ester C-O bonds at room temperature without using transition metals. The broad substrate scope and excellent functional

  我们发现，随着硫酰氟的促进，酰胺的羰基作为亲核试剂发挥作用，而醇的羟基被活化以作为亲电试剂官能化。这项研究表明，在不使用过渡金属的情况下，酰胺CN键很容易被精密的亲核试剂裂解形成酯CO键。用44个实例证明了广泛的底物范围和出色的官能团相容性，产率高达99％。
• [EN] AMINE COMPOUNDS<br/>[FR] DERIVES D'INDOLE SERVANT D'ANTAGONISTE DE SOMATOSTATINE
  申请人：TAKEDA CHEMICAL INDUSTRIES LTD

  公开号：WO2004046107A1

  公开（公告）日：2004-06-03

  The present invention provide a compound of the formula (I) wherein ring A represents an aromatic ring optionally having substituents; B, Y and Ya are the same or different and each represents a bond, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrogen atom, etc.; R4 and R5 are the same or different and each represents a hydrogen, etc.; R6 represents an indolyl group optionally having substituents; and Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibition activity and is useful for preventing and/or treating diseases associated with somatostatin.

  本发明提供了一种公式(I)的化合物，其中环A代表一个具有可选取代基的芳香环；B、Y和Ya相同或不同，分别代表一个键等；R1和R2相同或不同，每个代表一个氢原子等；R3代表一个氢原子等；R4和R5相同或不同，每个代表一个氢等；R6代表一个可选有取代基的吲哚基团；Z和Za相同或不同，每个代表一个氢原子等；或其盐或前药，具有生长抑素受体结合抑制活性，并且用于预防或治疗与生长抑素相关的疾病。
• [EN] DIHYDROPYRAZOLOPYRIDINE COMPOUNDS<br/>[FR] COMPOSES DE DIHYDROPYRAZOLOPYRIDINE
  申请人：MITSUBISHI PHARMA CORP

  公开号：WO2004014910A1

  公开（公告）日：2004-02-19

  The present invention provides dihydropyrazolopyridine compounds represented by the formula (I):wherein each symbol is as defined in the specification, optically active forms thereof, and pharmaceutically acceptable salts thereof and hydrates thereof. The compounds of the present invention show a selective and strong inhibitory activity on glycogen synthase kinase-3 beta (GSK-3β), and are useful as medicaments for prevention and/or treatment of diabetes, diabetic complications and neurodegenerative diseases or as immunopotentiators.

  本发明提供了由式(I)表示的二氢吡唑吡啶化合物，其中每个符号如规范中定义，其光学活性形式，以及其药学上可接受的盐和水合物。本发明的化合物显示出对糖原合成酶激酶-3β（GSK-3β）的选择性和强烈的抑制活性，并可用作预防和/或治疗糖尿病、糖尿病并发症和神经退行性疾病或免疫增强剂的药物。